Zhejiang East Asia Pharmaceutical Co., Ltd. (605177.SS) SHH

24.10

+1.5(+6.64%)

Updated at June 03 01:23PM

Currency In CNY

Valuation

Market Cap2B
Enterprise Value2.74B
P/E Ratio-23.32
PEG Ratio0.52
Price/Sales Ratio2.52
Price/Book Ratio1.45
Enterprise/Revenue3.23
Enterprise/EBITDA123.96

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterMarch 31, 2026

Profitability

Profit Margin-0.11
Operating Margin-0.11

Management Effectiveness

Return On Assets-0.03
Return On Equity-0.06

Income Statement

Revenue940.19M
Revenue/Share8.93
Gross Profit222.07M
EBITDA84.1M
Net Income-82.39M
Diluted EPS-0.73

Balance Sheet

Total Cash368.54M
Total Cash/Share3.25
Total Debt1.02B
Total Debt/Equity0.58
Current Ratio1.87
Book Value Per Share15.62

Price History

52-Week Change24.75
52-Week High24.7
52-Week Low17.03
Moving Average 50 Days21.18
Moving Average 200 Days20.53

Statistics

Average Volume3.17M
Shares Outstanding112.56M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio-0.05
Last Split FactorN/A
Last Split DateN/A